Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Graninger

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Chemotherapy|August 21, 2004
Clinical applications of levofloxacin for severe infectionsWolfgang Graninger, Markus Zeitlinger
Wiener Medizinische Wochenschrift (1946)|July 3, 2003
Cost-effectiveness in diagnosis of patients with long-standing feverHarald Wolf, Wolfgang Graninger
Wiener Klinische Wochenschrift|December 27, 2011
Bilateral retinal detachment in reactive arthritis: coincidence or association?Matthias Preusser, Hugo Ocampo, Wolfgang Graninger
The Journal of Antimicrobial Chemotherapy|July 31, 2003
Comparative activity of telithromycin against typical community-acquired respiratory pathogensAstrid Buxbaum, Sabine Forsthuber, Wolfgang Graninger, et al.
International Journal of Antimicrobial Agents|August 15, 2006
Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacinRafael Cantón, Harmut Lode, Wolfgang Graninger, et al.
Pharmacology|October 18, 2007
Daptomycin: a review 4 years after first approvalRobert Sauermann, Markus Rothenburger, Wolfgang Graninger, et al.
Pharmacology|October 19, 2006
The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applicationsClaudia Wagner, Wolfgang Graninger, Elisabeth Presterl, et al.
The Journal of Antimicrobial Chemotherapy|June 6, 2006
Antimicrobial and toxicological profile of the new biocide Akacid plusAstrid Buxbaum, Christina Kratzer, Wolfgang Graninger, et al.
Antimicrobial Agents and Chemotherapy|May 27, 2005
DNA in antibiotic preparations: absence of intact resistance genesMarkus Woegerbauer, Heimo Lagler, Wolfgang Graninger, et al.
Pharmacology|September 30, 2005
Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patientsVanessa Kulemann, Martin Bauer, Wolfgang Graninger, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Chemotherapy|August 21, 2004
Clinical applications of levofloxacin for severe infectionsWolfgang Graninger, Markus Zeitlinger
Wiener Medizinische Wochenschrift (1946)|July 3, 2003
Cost-effectiveness in diagnosis of patients with long-standing feverHarald Wolf, Wolfgang Graninger
Wiener Klinische Wochenschrift|December 27, 2011
Bilateral retinal detachment in reactive arthritis: coincidence or association?Matthias Preusser, Hugo Ocampo, Wolfgang Graninger
The Journal of Antimicrobial Chemotherapy|July 31, 2003
Comparative activity of telithromycin against typical community-acquired respiratory pathogensAstrid Buxbaum, Sabine Forsthuber, Wolfgang Graninger, et al.
International Journal of Antimicrobial Agents|August 15, 2006
Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacinRafael Cantón, Harmut Lode, Wolfgang Graninger, et al.
Pharmacology|October 18, 2007
Daptomycin: a review 4 years after first approvalRobert Sauermann, Markus Rothenburger, Wolfgang Graninger, et al.
Pharmacology|October 19, 2006
The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applicationsClaudia Wagner, Wolfgang Graninger, Elisabeth Presterl, et al.
The Journal of Antimicrobial Chemotherapy|June 6, 2006
Antimicrobial and toxicological profile of the new biocide Akacid plusAstrid Buxbaum, Christina Kratzer, Wolfgang Graninger, et al.
Antimicrobial Agents and Chemotherapy|May 27, 2005
DNA in antibiotic preparations: absence of intact resistance genesMarkus Woegerbauer, Heimo Lagler, Wolfgang Graninger, et al.
Pharmacology|September 30, 2005
Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patientsVanessa Kulemann, Martin Bauer, Wolfgang Graninger, et al.
Pageof 9